Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 20

1.

68Ga-PSMA-11 PET/CT in recurrent prostate cancer: efficacy in different clinical stages of PSA failure after radical therapy.

Ceci F, Castellucci P, Graziani T, Farolfi A, Fonti C, Lodi F, Fanti S.

Eur J Nucl Med Mol Imaging. 2018 Oct 22. doi: 10.1007/s00259-018-4189-7. [Epub ahead of print]

PMID:
30350010
2.

(18)F-FACBC (anti1-amino-3-(18)F-fluorocyclobutane-1-carboxylic acid) versus (11)C-choline PET/CT in prostate cancer relapse: results of a prospective trial.

Nanni C, Zanoni L, Pultrone C, Schiavina R, Brunocilla E, Lodi F, Malizia C, Ferrari M, Rigatti P, Fonti C, Martorana G, Fanti S.

Eur J Nucl Med Mol Imaging. 2016 Aug;43(9):1601-10. doi: 10.1007/s00259-016-3329-1. Epub 2016 Mar 10.

PMID:
26960562
3.

PET radiopharmaceuticals for imaging of tumor hypoxia: a review of the evidence.

Lopci E, Grassi I, Chiti A, Nanni C, Cicoria G, Toschi L, Fonti C, Lodi F, Mattioli S, Fanti S.

Am J Nucl Med Mol Imaging. 2014 Jun 7;4(4):365-84. eCollection 2014. Review.

4.

FDG PET/CT predictive role in follicular lymphoma.

Lopci E, Zanoni L, Chiti A, Fonti C, Santi I, Zinzani PL, Fanti S.

Eur J Nucl Med Mol Imaging. 2012 May;39(5):864-71. doi: 10.1007/s00259-012-2079-y. Epub 2012 Feb 22.

PMID:
22354449
5.

FDG PET and 90Y ibritumomab tiuxetan in patients with follicular lymphoma.

Lopci E, Santi I, Tani M, Maffione AM, Montini G, Castellucci P, Stefoni V, Rubello D, Fonti C, Zinzani P, Fanti S.

Q J Nucl Med Mol Imaging. 2010 Aug;54(4):436-41. Epub 2010 May 27.

PMID:
20823812
6.

Long-lasting hemianopia due to PCA.

Delaj L, D'Alessandro R, Stracciari A, Fonti C, Cretella L, Lodi R.

J Neurol. 2010 Sep;257(9):1562-4. doi: 10.1007/s00415-010-5540-5. Epub 2010 Mar 30. No abstract available.

PMID:
20352248
7.

FDG-PET in the assessment of patients with follicular lymphoma treated by ibritumomab tiuxetan Y 90: multicentric study.

Lopci E, Santi I, Derenzini E, Fonti C, Savelli G, Bertagna F, Bellò M, Botto B, Huglo D, Morschhauser F, Zinzani P, Fanti S.

Ann Oncol. 2010 Sep;21(9):1877-83. doi: 10.1093/annonc/mdq024. Epub 2010 Feb 10.

PMID:
20147744
8.

Cerebral functions and metabolism after antegrade selective cerebral perfusion in aortic arch surgery.

Pacini D, Di Marco L, Leone A, Tonon C, Pettinato C, Fonti C, Manners DN, Di Bartolomeo R.

Eur J Cardiothorac Surg. 2010 Jun;37(6):1322-31. doi: 10.1016/j.ejcts.2009.12.029. Epub 2010 Feb 6.

PMID:
20138537
9.

WNT16B is a new marker of cellular senescence that regulates p53 activity and the phosphoinositide 3-kinase/AKT pathway.

Binet R, Ythier D, Robles AI, Collado M, Larrieu D, Fonti C, Brambilla E, Brambilla C, Serrano M, Harris CC, Pedeux R.

Cancer Res. 2009 Dec 15;69(24):9183-91. doi: 10.1158/0008-5472.CAN-09-1016.

10.

Italian verb inflection in Alzheimer dementia.

Colombo L, Fonti C, Stracciari A.

Neuropsychologia. 2009 Mar;47(4):1069-78. doi: 10.1016/j.neuropsychologia.2008.12.035. Epub 2009 Jan 7.

PMID:
19171157
11.

When the past is lost: focal retrograde amnesia. Focus on the "functional" form.

Stracciari A, Fonti C, Guarino M.

Behav Neurol. 2008;20(3):113-25. doi: 10.3233/BEN-2008-0222.

12.

Functional focal retrograde amnesia: lost access to abstract autobiographical knowledge?

Stracciari A, Mattarozzi K, Fonti C, Guarino M.

Memory. 2005 Oct;13(7):690-9.

PMID:
16191819
13.

Verbal versus non-verbal performances in mild Alzheimer's disease.

Fonti C, Tempestini A, Bracceschi R, Cirignotta F, Stracciari A.

Arch Gerontol Geriatr Suppl. 2004;(9):183-6.

PMID:
15207412
15.

[The value of hematological diagnosis of cancer and medico-social prophylaxis].

FONTI C.

An Paul Med Cir. 1963 Jan;85:41-50. Italian. No abstract available.

PMID:
13958649
16.

[Early hematological diagnosis of cancer. Medico-social prevention].

FONTI CJ.

Sem Med. 1962 Aug 16;121:658-64. Spanish. No abstract available.

PMID:
13958650
17.

[Serodiagnosis of carcinoma and results of blood cultures of cancer patients].

FONTI C.

Krebsarzt. 1954 Oct;9(5):315-6. German. No abstract available.

PMID:
13222812
18.

[Hematologic diagnosis of cancer].

FONTI CJ.

Med Klin. 1954 Aug 27;49(35):1402-3. German. No abstract available.

PMID:
13203031
19.

[Hematological diagnosis of cancer].

SCHONBAUER L, FONTI CI.

Krebsarzt. 1954 Apr;9(2):104-6. German. No abstract available.

PMID:
13193028
20.

[The hematological diagnosis of cancer].

FONTI CJ.

Krebsarzt. 1954 Feb 1;9(1):30-5. Undetermined Language. No abstract available.

PMID:
13164285

Supplemental Content

Support Center